DAIICHI SANKYO COMPANY, LIMITED Logo

DAIICHI SANKYO COMPANY, LIMITED

A global pharmaceutical firm developing novel therapies with a focus on oncology and ADCs.

4568 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区日本橋本町三丁目5番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Daiichi Sankyo is a global pharmaceutical company focused on the research, development, and delivery of innovative medical solutions. The company's core business revolves around creating novel therapies, with a primary strategic focus on oncology. It is a leader in the science of antibody-drug conjugates (ADCs), a class of targeted cancer drugs. Beyond oncology, its portfolio and development pipeline include treatments for cardiovascular diseases and other specialty areas. The company manufactures and markets a range of prescription medicines, vaccines, and over-the-counter healthcare products, aiming to contribute to the enrichment of quality of life for patients worldwide by creating new standards of care.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for DAIICHI SANKYO COMPANY, LIMITED and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-05 03:06
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.3 KB
2025-08-07 05:49
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.8 KB
2025-07-17 02:04
Registration Form
発行登録書(株券、社債券等)
Japanese 24.8 KB
2025-07-09 02:32
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.2 KB
2025-06-24 06:02
Regulatory News Service
訂正発行登録書
Japanese 8.9 KB
2025-06-24 05:36
Post-Annual General Meeting Information
臨時報告書
Japanese 25.7 KB
2025-06-23 08:40
Regulatory News Service
訂正発行登録書
Japanese 8.9 KB
2025-06-23 07:44
Regulatory News Service
臨時報告書
Japanese 31.3 KB
2025-06-20 07:20
Governance Information
内部統制報告書-第20期(2024/04/01-2025/03/31)
Japanese 23.5 KB
2025-06-20 07:20
Registration Form
確認書
Japanese 8.1 KB
2025-06-20 07:19
Annual Report
有価証券報告書-第20期(2024/04/01-2025/03/31)
Japanese 3.0 MB
2025-06-09 05:20
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.4 KB
2025-05-12 05:57
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.5 KB
2025-04-09 09:02
Regulatory News Service
訂正発行登録書
Japanese 8.9 KB
2025-04-09 08:37
Regulatory News Service
臨時報告書
Japanese 18.4 KB

Automate Your Workflow. Get a real-time feed of all DAIICHI SANKYO COMPANY, LIMITED filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DAIICHI SANKYO COMPANY, LIMITED via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
WAKAMOTO PHARMACEUTICAL CO.,LTD. Logo
Develops gastrointestinal and ophthalmic drugs for the health challenges of an aging society.
Japan 4512
WELLBIOTEC CO.,LTD Logo
Diversified in biopharma, EV chargers, and lithium supply for batteries.
South Korea 010600
WHANIN PHARM CO.,LTD Logo
Develops and sells pharmaceuticals, specializing in CNS, cardiovascular, and GI drugs.
South Korea 016580
WooGeneB&GCO.,Ltd Logo
Manufactures veterinary medicines, vaccines, and supplements for livestock and aquatic animals.
South Korea 018620
Xbrane Biopharma Logo
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
Sweden XBRANE
Xintela AB Logo
Develops stem cell therapies for osteoarthritis and venous leg ulcers using proprietary technology.
Sweden XINT
Xspray Pharma Logo
Develops improved cancer drugs (PKIs) using patented tech to circumvent secondary patents.
Sweden XSPRAY
Y.B Urban Renewal - Residential Development LTD Logo Israel CSURE-M
YUHAN CORPORATION Logo
A pharmaceutical & chemical firm developing drugs, supplements, consumer products, and APIs.
South Korea 000100
YUKI GOSEI KOGYO CO.,LTD. Logo
Manufactures fine chemicals, amino acids, and APIs via organic synthesis for global industries.
Japan 4531

Talk to a Data Expert

Have a question? We'll get back to you promptly.